Physician profile
Loree J Lieving
NPI 1942214556
$897.92
in general payments reported to CMS, 2019-2025
18 companies · $40.72 in 2025
The $40.72 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.31 · 2020: $55.11 · 2021: $277 · 2022: $133 · 2023: $291 · 2024: $29.85 · 2025: $40.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $361.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $229.55 | 2019-2024 | Shingrix, Bexsero, Arexvy |
| Dexcom, INC. | $183.95 | 2021-2023 | Dexcom G6 Transmitter |
| Edwards Lifesciences Corporation | $141.64 | 2023 | Sapien 3 Ultra Resilia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.02 | 2021-2022 | |
| Abbvie INC. | $32.28 | 2022 | |
| Medtronic, INC. | $31.59 | 2023 | Venaseal |
| Kaleo, INC. | $29.47 | 2022 | |
| Allergan, INC. | $27.05 | 2019-2020 | |
| Novo Nordisk INC | $25.33 | 2019-2021 | |
| Genentech USA, INC. | $24.38 | 2020 | |
| Sanofi-Aventis U.S. LLC | $22.40 | 2025 | |
| Ethicon US, LLC | $19.74 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.02 | 2023 | Vpriv |
| Pfizer INC. | $18.32 | 2025 | |
| Antares Pharma, INC. | $17.39 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $14.22 | 2021 | |
| Seqirus USA INC | $12.75 | 2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Sanofi Pasteur INC. | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loree Lieving listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.